Post-COVID Pulmonary Changes Are “Routine” Cases Now Higher Risk Abstract The COVID 19 pandemic has produced lasting consequences that extend far beyond the acute infectious phase, fundamentally reshaping respiratory medicine, perioperative evaluation, and risk assessment across multiple clinical disciplines. Although the acute burden of severe SARS
Infectious Disease
Antibiotics for H. pylori: Why First-Line Treatment Fails and What Salvage Regimens Actually Work
Antibiotics for H. pylori: Why First-Line Treatment Fails and What Salvage Regimens Actually Work Key Takeaways pylori treatment has evolved dramatically due to rising antibiotic resistance, requiring physicians to abandon traditional approaches and adopt resistance-resilient strategies from the start. Bismuth quadruple therapy
Vancomycin for MRSA: Why Clinicians Are Reconsidering the Gold Standard in 2026
Vancomycin for MRSA: Why Clinicians Are Reconsidering the Gold Standard in 2026 Key Takeaways For decades, vancomycin has served as the cornerstone of treatment for infections caused by methicillin resistant Staphylococcus aureus (MRSA). Its widespread adoption established it as the default empiric therapy across a broad range of clinical
mRNA Vaccines Beyond COVID-19: What’s Next for Infectious Diseases?
mRNA Vaccines Beyond COVID-19 What’s Next for Infectious Diseases Abstract Messenger RNA vaccine technology came to global prominence during the COVID 19 pandemic, when rapid design, large scale manufacturing, and emergency authorization demonstrated the practical viability of this platform. Unlike traditional vaccines that rely on attenuated pathogens,
mRNA Vaccines in Pregnancy: Reassurance or Lingering Concerns?
mRNA Vaccines in Pregnancy: Reassurance or Lingering Concerns? Abstract This paper reviews the current body of evidence regarding the safety and effectiveness of messenger RNA COVID-19 vaccines during pregnancy and explores the broader implications for emerging mRNA vaccine platforms intended for use in pregnant populations.
Preventing the Next Pandemic: Critical Insights from SARS-CoV-2 Surveillance Systems
Preventing the Next Pandemic Critical Insights from SARS-CoV-2 Surveillance Systems Introduction Preventing the next global pandemic requires a clear understanding of the profound and multifaceted impact of SARS-CoV-2, the virus responsible for COVID-19. Since its emergence, SARS-CoV-2 has infected millions of people worldwide and caused
Silent Inflammation: The Hidden Driver of Multisystem Chronic Disease?
Silent Inflammation The Hidden Driver of Multisystem Chronic Disease Abstract Chronic low grade inflammation, often referred to as silent inflammation, is increasingly recognized as a persistent inflammatory state that occurs in the absence of the classical signs and symptoms associated with acute inflammation.
Long COVID and the Brain: Decoding Post-Viral Neuroinflammation
Long COVID and the Brain: Decoding Post-Viral Neuroinflammation Abstract Long COVID has emerged as a significant and evolving global health challenge, affecting millions of individuals following acute infection with SARS-CoV-2. While respiratory and systemic symptoms were initially the primary focus of clinical attention, it has
The “Code Sepsis” Fatigue: When Protocols Collide with Clinical Judgment
The “Code Sepsis” Fatigue: When Protocols Collide with Clinical Judgment Abstract The global adoption of standardized sepsis protocols has been a central strategy in improving outcomes for patients with suspected or confirmed sepsis. Initiatives such as early warning systems, sepsis bundles, and time based
Long COVID Treatment Breakthrough- From Symptoms to Science-Backed Solutions
